DR3 (TNFRSF25) (NM_148965) Human Recombinant Protein
SKU
TP762456
Purified recombinant protein of Human tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 1, Cys141-End, with N-terminal His tag, expressed in E.coli, 50ug
$226.00
In Stock*
Need Bulk or Customize
Customization Options:
- Bulk quantity
- Different host
- Tags
- Mutations
- Buffers
- SEC testing
- Concentration
Product Data | |
Species | Human |
---|---|
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
Protein Sequence
A DNA sequence encoding the region(Cys141-End) of TNFRSF25
|
Tag | N-His |
Predicted MW | 31.0 kDa |
Concentration | >0.05 µg/µL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 50 mM Tris-HCl, pH 8.0, 8 M urea |
Note | For testing in cell culture applications, please filter before use. Note that you may experience some loss of protein during the filtration process. |
Storage | Store at -80°C after receiving vials. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Shipping | Dry Ice |
Reference Data | |
RefSeq | NP_683866 |
Locus ID | 8718 |
UniProt ID | Q93038 |
Cytogenetics | 1p36.31 |
RefSeq Size | 1665 |
RefSeq ORF | 1278 |
Synonyms | APO-3; DDR3; DR3; GEF720; LARD; PLEKHG5; TNFRSF12; TR3; TRAMP; WSL-1; WSL-LR |
Summary | The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Cytokine-cytokine receptor interaction |
Write Your Own Review
FAQs |
SDS |
Recombinant Protein Resources |
SKU | Description | Size | Price | |
---|---|---|---|---|
LC407711 | TNFRSF25 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$134.00
|
|
LC407712 | TNFRSF25 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$134.00
|
|
LC418426 | TNFRSF25 HEK293T cell transient overexpression lysate (as WB positive control) | 20 ug |
$206.00
|
|
LY407711 | Transient overexpression lysate of tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 3 | 100 ug |
$436.00
|
|
LY407712 | Transient overexpression lysate of tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 4 | 100 ug |
$436.00
|
|
LY418426 | Transient overexpression lysate of tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 2 | 100 ug |
$665.00
|
|
Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.